ID: ALA5204078

Max Phase: Preclinical

Molecular Formula: C27H32FN5O3

Molecular Weight: 493.58

Associated Items:

Representations

Canonical SMILES:  CCn1cc(C(=O)Nc2ccc(C(=O)NCC(C)C)cc2)c(=O)c2cc(F)c(N3CCNCC3)cc21

Standard InChI:  InChI=1S/C27H32FN5O3/c1-4-32-16-21(27(36)31-19-7-5-18(6-8-19)26(35)30-15-17(2)3)25(34)20-13-22(28)24(14-23(20)32)33-11-9-29-10-12-33/h5-8,13-14,16-17,29H,4,9-12,15H2,1-3H3,(H,30,35)(H,31,36)

Standard InChI Key:  ZPCWTNSAXQQELH-UHFFFAOYSA-N

Associated Targets(Human)

microRNA 21 64692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 493.58Molecular Weight (Monoisotopic): 493.2489AlogP: 3.21#Rotatable Bonds: 7
Polar Surface Area: 95.47Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.90CX Basic pKa: 8.67CX LogP: 3.20CX LogD: 1.91
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.47Np Likeness Score: -1.35

References

1. Xi XX, Hei YY, Guo Y, Zhao HY, Xin M, Lu S, Jiang C, Zhang SQ..  (2022)  Identification of benzamides derivatives of norfloxacin as promising microRNA-21 inhibitors via repressing its transcription.,  66  [PMID:35561631] [10.1016/j.bmc.2022.116803]

Source